Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

PGD could save women from the agony of repeated miscarriages

01.07.2002


Women who suffer repeated unexplained miscarriages can be helped to have babies if preimplantation genetic diagnosis (PGD) is carried out on their embryos before they are placed in the womb.

Ms Carmen Rubio told the European Society of Human Reproduction and Embryology annual conference in Vienna today (Monday 1 July) that her research showed that chromosomal abnormalities (aneuploidies) in the embryos were important causes of unexplained recurrent miscarriages (RM) and implantation failure (IF). She and her colleagues had achieved normal pregnancy rates and a decreased risk of miscarriage in women with these conditions by screening the embryos for chromosomal abnormalities during IVF and transferring only the normal embryos to the women’s wombs.

Ms Rubio, co-ordinator of the PGD programme at the Instituto Valenciano de Infertilidad, Valencia, Spain, said: "We know already that non-inherited abnormalities in the number of chromosomes is a common cause of miscarriage and that embryos which fail to implant successfully during IVF and ICSI often have these abnormalities as well. We wondered whether chromosomal abnormalities, produced while the male or female sex cells are being formed, or during the early development of the embryo, might be an important factor in women with RM or IF."



The team carried out PGD in 71 RM couples where the woman had had two or more unexplained miscarriages, and in 42 IF couples who had had three or more unsuccessful IVF or ICSI attempts in the previous four years. A control group of 28 fertile women who were undergoing PGD for sex-linked diseases was added to the study.

The researchers found that the percentage of embryos with abnormal chromosomes was approximately a third higher in the RM and IF groups, compared with the control group. Ms Rubio said: "These differences were especially remarkable in embryos from women under 37 years old; these were twice as likely to be abnormal. This is significant because women under 37 are a better group for comparing the incidence of chromosomal abnormalities in embryos in RM and IF patients, because once a woman is over 37 her age becomes an additional risk factor for aneuploidies."

After transferring only the normal embryos to the women, the researchers achieved similar pregnancy rates in all three groups (34.3% in the RM group, 32.4% in the IF group and 29% in the control group), and the miscarriage rate was similar too (13%, 0% and 0% – 13% in the RM group representing a reduction from a high risk to a level similar to the estimated miscarriage rate in the general population of about 15%).

Ms Rubio said: "Our study shows that, in some couples suffering from repeated unexplained miscarriages or implantation failure, chromosomal abnormalities in the embryo can be the cause of the problem. High pregnancy rates and a decreased risk of further miscarriages can be achieved in these couples by using PGD to select only the normal embryos to be transferred into the uterus. PGD could also be used as a diagnostic tool to identify couples with an increased risk of producing embryos with chromosomal abnormalities and even couples whose embryos are all abnormal."

Further information:

Margaret Willson, information officerEmma Mason, information officer
Tel: +44 (0) 1536 772181Tel: +44 (0) 1376 563090
Fax: +44 (0) 1536 772191Fax: +44 (0) 1376 563272
Mobile: +44 (0) 7973 853347Mobile: +44 (0)7711 296986
Email: m.willson@mwcommunications.org.uk   Email: wordmason@aol.com

Press Office: (Sunday 30 June -Wednesday 3 July)

Margaret Willson, Emma Mason, Janet Blümli
Tel: +43 (0) 1 260 69 2010 or +43 (0) 1 260 69 2011
Fax: +43 (0) 1 260 69 2012

Emma Mason | EurekAlert!
Further information:
http://www.eshre.com/
http://conf.eshre.com/PDF/O-081.pdf

More articles from Health and Medicine:

nachricht PET imaging tracks Zika virus infection, disease progression in mouse model
20.09.2017 | US Army Medical Research Institute of Infectious Diseases

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Molecular Force Sensors

20.09.2017 | Life Sciences

Producing electricity during flight

20.09.2017 | Power and Electrical Engineering

Tiny lasers from a gallery of whispers

20.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>